Clinical Trial Update: To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating tolerance, pharmacodynamics, and pharmacokinetics of lanthanum polystyrene sulfonate powder for hyperphosphatemia; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• Lanthanum polystyrene sulfonate powder (lanthanum polystyrene sulfonate powder)

Snippet

Sponsor: Grand Life Science (Liaoning) Co., Ltd. | Conditions: Hyperphosphatemia | Phase 1, Phase 2 | Status: UNKNOWN